Socio‐demographic and clinical factors associated with the receipt of anti‐obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Olajide A Adekunle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Bariatric Surgery, Obesity, Anti-Obesity Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
There is a paucity of data on socio‐economic characteristics associated with the use of anti‐obesity medications (AOM) and metabolic and bariatric surgery (MBS) when accounting for clinical factors. This study characterized factors associated with the receipt of AOM prescriptions and MBS. Materials and Methods A cross‐sectional study was conducted using the All of Us (AoU) Research (v.8) data. Patients with obesity who received AOM or MBS between 2017 and 2023 were included. Descriptive statistics were used to summarize patient characteristics, while multivariable regression examined factors associated with the receipt of the treatments.
Results
Only 6.6% of 183 424 patients for AOM analysis, received an AOM prescription, while 1.8% underwent MBS among 93 146 patients. Being a man (vs. woman, adjusted odds ratio [aOR] = 0.62, 95% confidence interval [CI], 0.59–0.65), Medicare insurance holder (vs. private, aOR = 0.78, 95% CI, 0.72–0.84), retiree (vs. employed, aOR = 0.70, 95% CI, 0.66–0.75) and high school degree holders (vs. college, aOR = 0.85, 95% CI, 0.80–0.90) were associated with lower odds of receiving AOM. Being single (vs. married, aOR = 0.84, 95% CI, 0.74–0.96), retired (vs. employed, aOR = 0.63, 95% CI, 0.49–0.80), with body mass index (BMI) 35‐ < 40 (vs. ≥45, aOR = 0.13, 95% CI, 0.11–0.15) were associated with lower odds of MBS. Patients with dyslipidaemia and obstructive sleep apnoea had higher odds of receiving both treatments.
Conclusions
Disparities in obesity treatment exist. Male sex, older age, lower income and lower BMI were associated with lower odds of treatment, while dyslipidaemia and obstructive sleep apnoea were associated with higher odds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
- School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
ORCID-Profile: Olajide A Adekunle, Hamlet Gasoyan
Zitieren
APA
Adekunle, O. A., Le, P., Gupta, D. Y., Rothberg, M. B., Tran, H. T., Yue, Y., & Gasoyan, H. (2025). Socio‐demographic and clinical factors associated with the receipt of anti‐obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16544
Vancouver
Adekunle OA, Le P, Gupta DY, Rothberg MB, Tran HT, Yue Y, et al. Socio‐demographic and clinical factors associated with the receipt of anti‐obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16544
BibTeX
@article{Adekunle2025,
author = {Adekunle, Olajide A and Le, Phuc and Gupta, Dev Yash and Rothberg, Michael B and Tran, Ha T and Yue, Yihua and Gasoyan, Hamlet},
title = {Socio‐demographic and clinical factors associated with the receipt of anti‐obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16544}
}
EUVIMED